Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia

American Journal of Drug and Alcohol Abuse

Volumn 38, Issue 6, 2012, Pages 567-574

  Lai, Harry Man Xiong ^a,b   Sitharthan, Thiagarajan ^a  

^a University of Sydney   (Australia)

^b Greater Sydney Area Helicopter Emergency Medical Service Ambulance Service New South Wales Rescue Helicopter Base Bankstown Airport   (Australia)

Author keywords

Cannabis; Comorbidity; Dual diagnosis; Mental health; Substance misuse

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; AUSTRALIA; BIPOLAR DISORDER; CANNABIS ADDICTION; CHI SQUARE TEST; CHILD; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PERSONALITY DISORDER; SCHIZOPHRENIA; SCHOOL CHILD; SEVERE STRESS DISORDER;

ADOLESCENT; ADULT; AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHILD; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MARIJUANA ABUSE; MENTAL DISORDERS; MIDDLE AGED; NEW SOUTH WALES; SEX FACTORS; YOUNG ADULT;

EID: 84867370630     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2012.694523     Document Type: Article

References (44)

1. Ministerial Council on Drug Strategy. National alcohol strategy 2006-2011. Department of Health and Ageing, Canberra, 2006. Available at http:www.alcohol.gov.au/internet/alcohol/ publishing.nsf/Content/nas-06-09. Last accessed on February 11, 2012.
2. Australian Institute of Health and Wellbeing. 2007 National Drug Strategy Household Survey: First Results. Drug Statistics Series 2008b; no. 20. Cat. No. PHE 98. Canberra.
3. Farrell M. Cannabis dependence and withdrawal. Addiction 1999; 94:1277-1278.
4. Johnston LD, O'Malley PM, Bachman JG. Monitoring the Future Study: 1975-95 II. Washington, DC: Department of Health and Human Services, 1997.
5. Condon G,SmithN. Prevalence ofDrugUse:Key Findings from the 2002/2003 British Crime Survey. Development and Statistics Directorate, Home Office, UK 2003. Available at http://www. homeoffice.gov.uk/rds/pdfs2/r229.pdf. Last accessed on December 19, 2011.
6. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the epidemiological catchment area (ECA) study. J Am Med Assoc 1991; 264:2511-2518.
7. Wu LT, Kouzis AC, Leaf PJ. Influence of comorbid alcohol and psychiatric disorders on utilisation of mental health services in the National Comorbidity Survey. Am J Psychiatry 1999; 156:1230-1236.
8. Lai HMX, Huang QR. Comorbidity of mental health disorders and alcohol and other drug use disorders: Analysis of New South Wales inpatient data. Drug Alcohol Rev 2008; 28:235-242.
9. Lai HMX, Sitharthan TR. Comparison of inpatients with comorbid mental health disorders and drug and alcohol use disorders within general hospitals and psychiatric hospitals in NSW, Australia. J Subst Use 2012; 17:301-309.
10. Raphael B, Wooding S, Stevens G, Connor J. Comorbidity: cannabis and complexity. J Psychiatr Pract 2005; 11(3):161-176.
11. Hall W, Degenhardt L. Cannabis use and psychosis: A review of clinical and epidemiological evidence. Aust N Z J Psychiatry 2000; 24:217-226.
12. McKay DR, Tennant CC. Is the grass greener? The link between cannabis and psychosis. Med J Australia 2000; 172:284-286.
13. Castle DJ, Ames FR. Cannabis and the brain. Aust N Z J Psychiatry 1996; 30:179-183.
14. Pope HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: What is the nature of the association? Drug Alcohol Depend 2003; 69:303-310.
15. Solowji N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J. Cognitive functioning of long-term heavy cannabis user seeking treatment. J Am Med Assoc 2002; 287:1123-1132.
16. Gruber AJ, Pope HG, Hudson JI, Yurgelun-Todd D. Attributes of long-term heavy cannabis users: A case-control study. Psychol Med 2003; 33:1415-1422.
17. Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction 2008; 103:969-976.
18. Tayler FM. Marijuana as a potential respiratory track carcinogen: A retrospective analysis of a community hospital population. South Med J 1998; 81:1213-1216.
19. Zhang ZF, Morgenstern H, Spitz MH, Tashkin DP, Yu GP, Marshall JR, Hsu TC, Schantz SP. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999; 8:1071-1078.
20. Volkow ND. Substance use disorders in schizophreniaclinical implications of comorbidity. Schizophr Bull 2007; 35(3):469-472.
21. Swift W, Coffey C, Carlin JB, Degenhardt L, Patton GC. Adolescent cannabis users at 24 years: Trajectories to regular weekly use and dependence in young adulthood. Addiction 2008; 108(8):1361-1370.
22. van Gastel W, Wigman J, Monshouwer K, Kahn R, van Os J, Boks M, Vollebergh W. Cannabis use and subclinical positive psychotic experiences in early adolescence: Findings from a Dutch survey. Addiction 2011; 107:381-387.
23. Fontes MA, Bolla KI, Cunha PJ, Almeida PP, Jungerman F, Laranijeira RR, Bressan RA, Lacerda ALT. Cannabis use before age 15 and subsequent executive functioning. Br J Psychiatry 2011; 198:442-447.
24. Degenhardt L, Hall W, Lynskey M. The relationship between cannabis use, depression and anxiety among Australian adults findings from the National Survey of Mental Health and Well-Being. Soc Psychiatr Psychiatr Epidemiol 2001; 36:219-227.
25. Black J, Heffner JL, Anthenelli RM, Beavers JN, Albertz A, Blom T, Adler C, DelBello MP. Diagnosing alcohol and cannabis use disorders in adolescents with bipolar disorder: A preliminary investigation. J Dual Diagn 2012; 8(1):13-18.
26. National Centre for Classification in Health (NCCH). International Statistical Classification of Disease and Related Health Problems, 10th revision, Australian Modification (ICD- 10-AM),NCCH, Sydney, 2000.
27. Australian Institute of Health and Wellbeing. The coding workforce shortfall. November 2010; Cat. No. HWL 46. Canberra.
28. Health Information Management Association Australian. Education Service 2012. Available at http://himaa2.org.au/edu cation/?qnode/139. Last accessed on February 15, 2012.
29. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 2007; 370:319-328.
30. NSW Department of Health. Annual Report 2009-10 NSW Health. NSW Department of Health, Sydney, Australia, 2010. Available at http://www.health. nsw.gov.au/pubs/2010/annual report10.html. Last accessed on January 28, 2012.
31. Grace RF, Shenfield G, Tennant C. Cannabis and psychosis in acute psychiatric admissions. Drug Alcohol Rev 2000; 19:287-290.
32. Hall W, Goldstein G, Andrews G, Lapsley H, Bartels R, Silove D. Estimating the economic costs of schizophrenia. Schizophr Bull 1985; 11:598-611.
33. Degenhardt L, Hall W, Lynskey MT. Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 2000; 96:1603-1614.
34. Agrawal A, Neale MC, Prescott CA, Kendler KS. Cannabis and other illicit drugs: Comorbid use and abuse/dependence in males and females (Erratum). Behav Gene 2004; 34(3):217-228.
35. Sundram S. Cannabis and neurodevelopment: Implications for psychiatric disorders. Hum Psychopharmacol 2006; 21(4):245-254.
36. Trezza V, Cuomo V, Vanderschuren LJ. Cannabis and the developing brain: Insights from behaviour. Eur J Pharmacol 2008; 585:441-452.
37. Di Forti M, Morrison PD, Butt A, Murray RM. Cannabis use and psychiatric and cognitive disorders: The chicken or the egg? Curr Opin Psychiatry 2007; 20:228-234.
38. Laquille X. Related, induced and associated psychiatric disorders to cannabis. Pevue Du Praticien 2005; 55(1):30-34.
39. Stinson F, Ruan WJ, Pickering R, Grant BF. Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity. Psychol Med 2006; 36:1447-1460.
40. Green B, Young R, Kavanagh DJ. Cannabis use and misuse prevalence among people. Br J Psychiatry 2005; 187:306-313.
41. Zuardi AW. History of cannabis as a medicine: A review. Rev Bras Psiquiatr 2006; 28:153-157.
42. Herderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care 2006; 44(11):1011-1019.
43. Paglia A, Room R. Preventing substance use problems among youth: A literature review and recommendations. J Prim Prev 1999; 20(1):3-50.
44. Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012; 37:11-24